Premium
[P2–002]: EFFECT OF SOLANEZUMAB ON BIOMARKERS OF NEURODEGENERATION IN THE EXPEDITION3 TRIAL IN MILD ALZHEIMER DISEASE
Author(s) -
Schwarz Adam J.,
Sundell Karen L.,
Lachno David Richard,
Case Michael G.,
Suhy Joyce,
Pontecorvo Michael J.,
Dean Robert A.,
Siemers Eric R.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.650
Subject(s) - placebo , medicine , atrophy , biomarker , oncology , gastroenterology , urology , pharmacology , pathology , chemistry , biochemistry , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom